Phase 1 Solid Advanced Tumor Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors.

Solid Advanced Tumor

Betta Pharmaceuticals Co., Ltd.164 enrolled1 locationNCT07448116

Recruiting

Phase 1Phase 2

Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas

LymphomaNSCLC (Non-small Cell Lung Cancer)Solid Advanced Tumor

OSE Immunotherapeutics41 enrolled11 locationsNCT05751798